Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-9-12
pubmed:abstractText
Regenerating islet-derived family, member 4 (Reg IV) is a candidate marker for cancer and inflammatory bowel disease. In the present study, immunohistochemical analysis of Reg IV was performed in various human neoplastic (n = 289) and non-neoplastic tissues. In the stomach, foveolar epithelium was negative for Reg IV, whereas goblet cells of intestinal metaplasia and neuroendocrine cells at the base of intestinal metaplasia expressed Reg IV. Neuroendocrine cells of the small intestine and colon showed strong expression of Reg IV, whereas goblet cells of the small intestine and colon showed weak or no expression of Reg IV. Insulin-producing beta cells of the endocrine pancreas were positive for Reg IV. Among 143 gastric adenocarcinomas, Reg IV expression was detected in 42 (29.4%) and was associated with both the intestinal mucin phenotype and neuroendocrine differentiation. No association was found between Reg IV expression and clinical characteristics such as tumour stage and patient prognosis. Of 36 colorectal adenocarcinomas, 13 (36.1%) were positive for Reg IV, which was associated with tumour stage (p = 0.0379, Fisher's exact test). Expression of Reg IV was detected in 14 (93.3%) of 15 colorectal carcinoid tumours. Reg IV expression was also detected in 5 (21.7%) of 23 ductal adenocarcinomas of the pancreas. In contrast, lung cancers (n = 30) and breast cancers (n = 30) did not express Reg IV. This is the first immunohistochemical analysis of the expression and distribution of Reg IV protein in human tumours. These data suggest that Reg IV is expressed by gastrointestinal and pancreatic tumours, including adenocarcinomas and carcinoid tumours, and that Reg IV is associated with intestinal and neuroendocrine differentiation of the stomach and gastric carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3417
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
pubmed:issnType
Print
pubmed:volume
207
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
185-98
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16086444-Adenocarcinoma, pubmed-meshheading:16086444-Adenoma, pubmed-meshheading:16086444-Blotting, Western, pubmed-meshheading:16086444-Breast Neoplasms, pubmed-meshheading:16086444-Carcinoid Tumor, pubmed-meshheading:16086444-Cell Differentiation, pubmed-meshheading:16086444-Cell Line, Tumor, pubmed-meshheading:16086444-Colon, pubmed-meshheading:16086444-Colorectal Neoplasms, pubmed-meshheading:16086444-Female, pubmed-meshheading:16086444-Humans, pubmed-meshheading:16086444-Immunohistochemistry, pubmed-meshheading:16086444-Intestine, Small, pubmed-meshheading:16086444-Lectins, C-Type, pubmed-meshheading:16086444-Lung Neoplasms, pubmed-meshheading:16086444-Neoplasm Proteins, pubmed-meshheading:16086444-Pancreas, pubmed-meshheading:16086444-Pancreatic Neoplasms, pubmed-meshheading:16086444-Phenotype, pubmed-meshheading:16086444-RNA, Messenger, pubmed-meshheading:16086444-RNA, Neoplasm, pubmed-meshheading:16086444-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16086444-Stomach, pubmed-meshheading:16086444-Stomach Neoplasms, pubmed-meshheading:16086444-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
pubmed:affiliation
Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't